TGen case study documented first reported U.S. transmission of COVID from a pet owner to pets
On Nov. 1, 2021, for the first time in the U.S., the transmission of COVID-19 from pet parent…
-
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine
Highly Pathogenic Avian Influenza Confirmed in Clackamas County, Oregon
On Nov. 4, 2026, the U.S. Department of Agriculture’s (USDA) National Veterinary Services Laboratories (NVSL) confirmed Highly Pathogenic Avian Influenza…
-
Two new candidate vaccines join Ebola trial as treatment research advances
On Nov. 4, 2026, the World Health Organization (WHO) have recommended adding two new Ebola vaccine candidates to…
-
Agriculture | Biotechnology | Genomics | USDA
Predicting jumping genes’ roles in changing genome size
On Nov. 2, 2026, Scientists at Ohio State University who study how transposable elements, also called transposons or…
-
Biotechnology | FDA | NIH | Therapeutics
FDA Issues Guidance for Cellular and Gene Therapy Products
On Nov. 2, 2026, the U.S. Food and Drug Administration (FDA) published guidance recommendations for developing a science-…
-
New York State Department of Health and Lewis County Public Health Report Pediatric Measles-Associated Death
On Nov. 2, 2026, cased on information currently available, the New York State Department of Health and Lewis…
-
Biotechnology | FDA | HIV | Therapeutics
U.S. FDA grants tentative approval for Dr. Reddy’s twice-yearly injectable lenacapavir, advancing access to HIV prevention across 120 countries
On Nov. 2, 2026, Dr. Reddy’s Laboratories announced that the U.S. Food and Drug Administration (FDA) has granted…
-
USDA Confirms Highly Pathogenic Avian Influenza in a Dairy Herd in Indiana
On Nov. 2, 2026, U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) National Veterinary Services…
-
Flu Vaccine Now Required for Many Airmen, Guardians, and DAF Civilians
On Oct. 31, 2026, Airmen and Guardians in the Active and Reserve component, as well as civilian employees,…
-
Routine Milk Tank Testing Detects Colorado’s First Dairy HPAI Case Since 2024
On Oct. 30, 2026, the U.S. Department of Agriculture’s National Veterinary Services Laboratory (NVSL) has confirmed a detection…
-
Cambrex Breaks Ground on $120 Million Expansion in Charles City, Iowa
On Oct. 30, 2026, Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the groundbreaking of…
-
historic measles outbreak hits Pennsylvania Amish, Worst in 35 years
On Oct. 30, 2026, the Associated Press reported that Lancaster County in central Pennsylvania, home to the largest…
-
First patient undergoes pioneering stem-cell treatment for Parkinson’s
On Oct. 30, 2026, a patient has undergone pioneering stem-cell therapy to treat Parkinson’s disease, the Japanese drugmaker…
-
Robot could improve diagnosis, treatment of small intestine disorders
On Oct. 28, 2026, researchers from UT Southwestern Medical Center reported that a bioinspired soft enteroscopic robot (BIOSENTER)…
-
Landmark studies map how genetic differences drive human diseases
On Oct. 28, 2026, in three landmark studies published in Nature, Australian researchers announced they have made major…
-
IAVI awarded $36 million from BARDA for Bundibugyo virus vaccine development
On Oct. 28, 2026, IAVI, a global nonprofit biomedical research organization, together with partners Hilleman Laboratories, SK bioscience,…
-
UT Introduces UT Dell Medicine, Shares Plans for Advanced Specialty Care in Central Texas
On Oct. 27, 2026, the University of Texas at Austin introduced UT Dell Medicine, its academic health system,…
-
Anthropic Acquires Mithril Medicine, a one-person company developing treatments for rare forms of muscular dystrophy
On Oct. 27, 2026, Anthropic announced the acquisition of Mithril Medicine, a one-person company that has been developing…
-
First human endothelial cell atlas maps how blood vessels age
On Oct. 27, 2026, to uncover how endothelial cells, the inner linings of blood vessels. change over the…
-
Biotechnology | Chemistry | FDA | Oncology | Pharmaceutical
Merck Drug Reduces Risk of Death by 32% Compared to Chemotherapy Awarded FDA Priority Review
On Oct. 26, 2026, Merck announced the first results from the pivotal Phase 3 TroFuse-005 trial evaluating sacituzumab…
-
FDA Approves First Once-Weekly Insulin for Type 2 Diabetes Mellitus in Pediatric Patients
On Oct. 23, 2026, the U.S. Food and Drug Administration announced it has approved Awiqli (insulin icodec-abae) injection,…
-
CDC Reports 4,811 Patients Admitted to Hospitals with Influenza, Cases Continue to Rise
On Oct. 23, 2026, the U.S. Disease Control and Prevention (CDC) reports that 4,811 patients were admitted to…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
US CDC Reports Measles cases rise to 4,588 as outbreak continues
On Oct. 23, 2026, The US Centers for Disease Control and Prevention (CDC) reported 4,588 measles cases in…
-
Artificial Intelligence | Biotechnology | Chemistry | Diagnostics | Infectious Disease | Quantum | Rare Disease | Stem Cell | Vaccine
Anthropic Announces Open call for guest investigators in the life sciences
On Oct. 22, 2026, Anthropic is inviting members of the life sciences community to apply to work with…
-
novel mRNA cancer vaccine helps reduce the chances of melanoma patients’ tumors returning
On Oct. 22, 2026, a first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come…
-
Lilly breaks ground in Richmond to expand next-generation cancer medicines
On Oct. 22, 2026, Eli Lilly broke ground on a new $5 billion manufacturing facility just west of…
-
Gilead to Acquire PepStar Therapeutics’ Oral IL-23R Inhibitor HCXT-2001, Strengthening Its IBD Inflammation Pipeline for $1.275 billion in Cash
On Oct. 22, 2026, Gilead Sciences announced that it has entered into a definitive agreement to acquire an…
-
1st Recipient of iPS Cell Sheet Transplant Set for Discharge
On Oct. 21, 2026, a woman in her 50s who received the first transplant of heart muscle cell…
-
EQT to Acquire QIAGEN for $12.1 Billion in Cash
On Oct. 21, 2026, QIAGEN and the EQT XI fund announced an agreement under which Crown NL Bidco…
-
U.S. FDA Approved GSK’s Hibsago (bepirovirsen) for treatment of chronic hepatitis B
On Oct. 20, 2026, GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen)…
-
Notre Dame investing $275 Million in biomedical research
On Oct. 20, 2026, the University of Notre Dame announced it is investing $275 million in assembling new…
